NPR : News

Filed Under:

Obama Tackles Rx Drug Shortages

President Obama is wielding a unilateral prerogative of his office – the executive order – to get something done about a worsening shortage of essential drugs.

It's a problem that earlier this month one administration official called "a dire public health situation." Many thousands of patients with cancer, life-threatening infections, cardiac disease, severe gastrointestinal disorders and many other conditions aren't able to get the drugs they need.

Every day, doctors, nurses and pharmacy managers scramble to find workarounds. Often, they say, patients aren't aware they're getting a substitute for the preferred, first-line drug that health providers would normally use.

With no immediate prospect of a congressional fix, the president is extending his recent penchant for executive orders to the drug shortage problem.

His order has three elements:

  • The Food and Drug Administration will broaden its requirements and voluntary requests for drug manufacturers to report potential supply problems.
  • The FDA will speed up reviews of manufacturers' applications to begin or alter production of a drug in potentially short supply.
  • The FDA will tell the Justice Department about possible instances of collusion or price gouging among drug distributors taking advantage of shortages.

The White House says it's beefing up the FDA's staff to carry out the new mandates.

These are stopgaps. Obama also is expected to announce his support for pending legislation that would require drug manufacturers to notify the FDA six months in advance of a potential shortage. At the moment, companies are only required to notify the government is they're discontinuing production of drugs deemed medically necessary.

And expert observers say that legislation, if it passes, will only be a partial solution to a problem that's rooted in the gradual consolidation of drug production – especially the manufacture of injectable drugs used mainly in hospitals. Most of these are older, generic medicines with thin profit margins.

The Department of Health and Human Services has just put out a 20-page economic analysis of the problem.

Only seven companies make the vast majority of these drugs. So when a particular company has contamination on its production line, or can't get an essential ingredient from abroad, other manufacturers can't pick up the slack.

Meanwhile, the problem is getting steady worse. Last year the FDA reported 178 drug shortages, although some sources say the number was really 211. Earlier this month, the number for 2011 had already surpassed that.

Copyright 2011 National Public Radio. To see more, visit http://www.npr.org/.

NPR

On Television, More Transgender Characters Come Into Focus

Now that it's more common to see gay characters on TV, is the medium turning to transgender people for fresh stories? NPR's Neda Ulaby looks at TV's crop of transgender and "gender fluid" characters.
NPR

Bake Bread Like A Pioneer In Appalachia ... With No Yeast

Bacteria can make a bread rise and give it a cheesy flavor. That's the secret ingredient in salt rising bread, which dates to the late 1700s in Appalachia, when bakers didn't have yeast on hand.
NPR

Pennsylvania Congresswoman Goes All In For Obamacare

Does Rep. Allyson Schwartz's pro-Affordable Care Act television ad signal a new thinking among Democrats running in statewide races?
NPR

Weekly Innovation: An Inflatable Car Seat That Comes In A Backpack

Parents, you are going to want to read about this prototype from Volvo. It's fully inflatable and designed to make what's normally a clunky and heavy seat both lighter and more portable.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.